Isoray, Inc. (ISR)
ISRPrice: $0.38
Fair Value: 🔒
🔒score
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the t... more
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotop... more
Description
Shares
| Market Cap | $0 | Exchange | AMEX |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Lori A. Holmes-Woods |
| IPO Date | 2002-05-31 | CAGR | -0.05% |
| Employees | 66 | Website | isoray.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ISR chart loading...
Fundamentals
Technicals
| Enterprise Value | $95.26M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 282.32 | P/B Ratio | 0.58 |
| P/CF Ratio | -2.64 | P/FCF Ratio | -1.45 |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -100% | Gross Margin | -1.5% |
| Operating Margin | -184.63% | Profit Margin | -197.29% |
| ROE | -0.39% | ROA | -0.37% |
| ROCE | -0.36% | Current Ratio | 15.09 |
| Quick Ratio | 15.09 | Cash Ratio | 2.22 |
| Debt/Equity | 0.01 | Interest Coverage | -437.63 |
| Altman Z Score | — | Piotroski Score | — |